Volume 13, Issue 1 pp. 124-128
Original Article
Free Access

Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis

Tadashi Iwao M. D.

Corresponding Author

Tadashi Iwao M. D.

Second Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Second Department of Medicine, Asahi-Machi 67, Kurume-Shi, Fukuoka-Ken, Japan (830)===Search for more papers by this author
Atsushi Toyonaga

Atsushi Toyonaga

Second Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Search for more papers by this author
Michihiro Sumino

Michihiro Sumino

Second Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Search for more papers by this author
Kohsuke Takagi

Kohsuke Takagi

Second Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Search for more papers by this author
Kazunori Ohkubo

Kazunori Ohkubo

Second Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Search for more papers by this author
Rintaroh Inoue

Rintaroh Inoue

Second Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Search for more papers by this author
Kyuichi Tanikawa

Kyuichi Tanikawa

Second Department of Medicine, Kurume University School of Medicine, Kurume, Japan

Search for more papers by this author
First published: January 1991
Citations: 26

Abstract

We studied 14 patients with portal hypertension and cirrhosis using portal and hepatic vein catheterizations to determine the effects of transdermal application of nitroglycerin tape (containing 10 mg of nitroglycerin and capable of releasing 6 to 7 mg of nitroglycerin in 12 hr) on splanchnic hemodynamics. Patients randomly received nitroglycerin (n = 7) or a placebo (n = 7). No significant changes were observed after the administration of the placebo. In contrast, transdermal nitroglycerin caused a significant reduction in portal pressure, as evaluated by measurements of the portal venous pressure gradient (−22%, p < 0.01). The reduction of portal pressure was due to a decrease in the portal venous pressure, with no changes in the free hepatic venous pressure. Despite the fall in portal pressure, the hepatic blood flow was maintained. These findings suggest that transdermal nitroglycerin could be potentially useful in the treatment of portal hypertension associated with cirrhosis. (HEPATOLOGY 1991;13:124–128).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.